BHC Stock: Price, Earnings History and SEC Filings
Bausch Health Companies Inc. (BHC) last traded at $8.20, down 7.97% on the latest session and up 40.7% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $1.77 against an analyst estimate of $1.08, a beat of 63.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BHC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $1.77 | $1.08 | +63.89% |
| Jun 2026 | Jul 29, 2026 | $1.26 | $0.96 | +31.25% |
| Mar 2026 | Apr 29, 2026 | $0.78 | $0.81 | -3.70% |
| Dec 2025 | Feb 18, 2026 | $1.08 | $1.21 | -10.74% |
BHC beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How BHC reacts to earnings
Across its last 8 earnings releases, BHC moved 10.5% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-28 | After close | +28.76% |
| 2026-07-29 | After close | +28.85% |
| 2026-04-29 | After close | +2.33% |
| 2026-02-18 | After close | -4.20% |
| 2026-01-13 | Before open | +0.13% |
| 2025-10-29 | After close | +12.03% |
| 2025-07-30 | After close | -7.82% |
| 2025-04-30 | After close | +0.00% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
BHC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $10.3B | $157M | $1.0B | 1.5% | $0.42 |
| 2024 | $9.6B | -$46M | $1.3B | -0.5% | $-0.13 |
| 2023 | $8.8B | -$592M | $817M | -6.8% | $-1.62 |
| 2022 | $8.1B | -$225M | -$946M | -2.8% | $-0.62 |
| 2021 | $8.4B | -$948M | $1.2B | -11.2% | $-2.64 |
| 2020 | $8.0B | -$560M | $809M | -7.0% | $-1.58 |
| 2019 | $8.6B | -$1.8B | $1.2B | -20.8% | $-5.08 |
| 2018 | $8.4B | – | $1.3B | – | $-11.81 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for BHC
- 10-Q · Oct 29, 2026
- 8-K · Oct 28, 2026Results of operations, Financial statements and exhibits
- 10-Q · Jul 30, 2026
- 8-K · Jul 29, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 1, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 19, 2026Shareholder vote
- 10-Q · Apr 30, 2026
- 8-K · Apr 29, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 8, 2026
- 8-K · Mar 2, 2026Officer or director change
Insider filing activity
BHC insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
BHC news
- Up 55% in October: Is Bausch Health’s turnaround just getting started?Oct 30, 2026 · finance.yahoo.com
- BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook RisesOct 29, 2026 · finance.yahoo.com
- Bausch Health Companies Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- What Bausch Health Cos (BHC) Said on Its Q3 Earnings CallOct 29, 2026 · marketbeat.com
- Bausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesOct 28, 2026 · finance.yahoo.com
- Bausch (BHC) Reports Q3 Earnings: What Key Metrics Have to SayOct 28, 2026 · finance.yahoo.com
- Bausch: Q3 Earnings SnapshotOct 28, 2026 · finance.yahoo.com
- Bausch Health soars on earnings beat and raised outlookOct 28, 2026 · finance.yahoo.com
About Bausch Health Companies Inc.
Bausch Health Companies Inc. (BHC) is a US-listed public company on NYSE. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in NJ. Its fiscal year ends in December.